The NPD values show a gradient of abnormalities, from CF patients with inadequate pancreas through CF patients with sufficient pancreas to cystic fibrosis transmembrane regulator-related disorders (CFTR-RD) heterozygotes and healthy individuals [17]. This evidence concerns the gene CFTR and cystic fibrosis.